Abstract
Tardive dyskinesia is a serious, disabling and potentially permanent, neurological hyperkinetic movement disorder that occurs after months or years of taking psychotropic drugs. The pathophysiology of tardive dyskinesia is complex, multifactorial and still not fully understood. A number of drugs were tried for the management of this motor disturbance, yet until now no effective and standard treatment has been found. It is very disappointing to realize that the introduction of antipsychotics from the second generation has not significantly decreased the prevalence and incidence of tardive dyskinesia. Therefore, the management of this motor disturbance remains an actual topic as well as a challenge for clinicians. This review summarizes recent relevant publications concerning the treatment of tardive dyskinesia.
Original language | English |
---|---|
Pages (from-to) | 321-334 |
Number of pages | 14 |
Journal | Psychiatry and Clinical Neurosciences |
Volume | 69 |
Issue number | 6 |
DOIs | |
State | Published - 1 Jun 2015 |
Keywords
- first-generation agents
- management
- schizophrenia
- second-generation agents
- tardive dyskinesia
ASJC Scopus subject areas
- General Neuroscience
- Neurology
- Clinical Neurology
- Psychiatry and Mental health